A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age

References

• Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, Luksic I, Nair H, McAllister DA, Campbell H, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health. 2018;6(7):e744–10. doi:10.1016/S2214-109X(18)30247-X.
   PubMed Web of Science ®Google Scholar
• DeMuri G, Wald ER. Acute bacterial sinusitis in children. Pediatr Rev. 2013;34(10):429–37. quiz 437. doi:10.1542/pir.34-10-429.
   PubMedGoogle Scholar
• Van Dyke MK, Pircon JY, Cohen R, Madhi SA, Rosenblut A, Macias Parra M, Al-Mazrou K, Grevers G, Lopez P, Naranjo L, et al. Etiology of acute otitis media in children less than 5 years of age: a pooled analysis of 10 similarly designed observational studies. Pediatr Infect Dis J. 2017;36(3):274–81. doi:10.1097/INF.0000000000001420.
   PubMed Web of Science ®Google Scholar
• Craven V, Everard ML. Protracted bacterial bronchitis: reinventing an old disease. Arch Dis Child. 2013;98(1):72–6. doi:10.1136/archdischild-2012-302760.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper – February 2019. [accessed 2022 June 28]. https://apps.who.int/iris/bitstream/handle/10665/310970/WER9408-85-103.pdf?sequence=2&isAllowed=y.
   Google Scholar
• Prevnar 13® pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]. Philadelphia, PA: Pfizer Inc; 2017.
   Google Scholar
• Pfizer Inc. Pfizer receives World Health Organization prequalification for multi-dose vial presentation of Prevenar 13®. [accessed 2022 Dec 9]. http://www.pfizer.com/news/press-release/press-release-detail/pfizer_receives_world_health_organization_prequalification_for_multi_dose_vial_presentation_of_prevenar_13
   Google Scholar
• Berman-Rosa M, O’Donnell S, Barker M, Quach C. Efficacy and effectiveness of the PCV-10 and PCV-13 vaccines against invasive pneumococcal disease. Pediatrics. 2020;145(4):e20190377. doi:10.1542/peds.2019-0377.
   PubMed Web of Science ®Google Scholar
• de Oliveira, LH, Camacho LA, Coutinho ES, Martinez-Silveira MS, Carvalho AF, Ruiz-Matus C, Toscano CM. Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review. PLoS One. 2016;11(12):e0166736. doi:10.1371/journal.pone.0166736.
   PubMed Web of Science ®Google Scholar
• Lai X, Wahl B, Yu W, Xu T, Zhang H, Garcia C, Qin Y, Guo Y, Yin Z, Knoll MD, et al. National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: modelled estimates for 2010–17. Lancet Reg Health West Pac. 2022;22:100430. doi:10.1016/j.lanwpc.2022.100430.
   PubMedGoogle Scholar
• Fu J, Li L, Liang Z, Xu S, Lin N, Qin P, Ye X, McGrath E. Etiology of acute otitis media and phenotypic-molecular characterization of Streptococcus pneumoniae isolated from children in Liuzhou, China. BMC Infect Dis. 2019;19(1):168. doi:10.1186/s12879-019-3795-8.
   PubMedGoogle Scholar
• Ning G, Wang X, Wu D, Yin Z, Li Y, Wang H, Yang W. The etiology of community-acquired pneumonia among children under 5 years of age in mainland China, 2001-2015: a systematic review. Hum Vaccin Immunother. 2017;13(11):2742–50. doi:10.1080/21645515.2017.1371381.
   PubMed Web of Science ®Google Scholar
• Ding Y, Geng Q, Tao Y, Lin Y, Wang Y, Black S, Zhao G, Zhang T. Etiology and epidemiology of children with acute otitis media and spontaneous otorrhea in Suzhou, China. Pediatr Infect Dis J. 2015;34(5):e102–106. doi:10.1097/INF.0000000000000617.
   PubMed Web of Science ®Google Scholar
• Fu J, Yi R, Jiang Y, Xu S, Qin P, Liang Z, Chen J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: a meta-analysis. BMC Pediatr. 2019;19(1):424. doi:10.1186/s12887-019-1722-1.
   PubMed Web of Science ®Google Scholar
• Pfizer Inc. Pfizer’s Prevenar 13® receives approval for use in infants and children in China. [accessed 2022 Dec 9]. https://www.pfizer.com/news/press-release/press-release-detail/pfizer_s_prevenar_13_receives_approval_for_use_in_infants_and_children_in_china.
   Google Scholar
• Li R, Huang L, Mo S, Li J, Zhou X, Chen Z, Liang J, Young M Jr., Giardina PC, Scott DA. Safety, tolerability, and immunogenicity of 7-valent pneumococcal conjugate vaccine in older infants and young children in China who are naive to pneumococcal vaccination: results of a phase 4 open-label trial. Vaccine. 2015;33(30):3580–5. doi:10.1016/j.vaccine.2015.05.042.
   PubMed Web of Science ®Google Scholar
• Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282(1821):20143085. doi:10.1098/rspb.2014.3085.
   PubMed Web of Science ®Google Scholar
• Waight PA, Andrews NJ, Ladhani NJ, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15(6):629. doi:10.1016/S1473-3099(15)70044-7.
   PubMed Web of Science ®Google Scholar
• von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, Madhi SA, Zell ER, Verani JR, O’Brien KL, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014;371(20):1889–99. doi:10.1056/NEJMoa1401914.
   PubMed Web of Science ®Google Scholar
• Lepoutre A, Varon E, Georges S, Dorleans F, Janoir C, Gutmann L, Levy-Bruhl D, Microbiologists of the Epibac, ORP Networks. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012. Vaccine. 2015;33(2):359–66. doi:10.1016/j.vaccine.2014.11.011.
   PubMed Web of Science ®Google Scholar
• Mackenzie GA, Hill PC, Jeffries DJ, Hossain I, Uchendu U, Ameh D, Ndiaye M, Adeyemi O, Pathirana J, Olatunji Y, et al. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in the Gambia: a population-based surveillance study. Lancet Infect Dis. 2016;16(6):703–11. doi:10.1016/S1473-3099(16)00054-2.
   PubMed Web of Science ®Google Scholar
• Jayasinghe S, Menzies R, Chiu C, Toms C, Blyth CC, Krause V, McIntyre P. Long-term impact of a ”3 + 0” schedule for 7- and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002-2014. Clin Infect Dis. 2017;64(2):175–83. doi:10.1093/cid/ciw720.
   PubMed Web of Science ®Google Scholar
• Wijayasri S, Hillier K, Lim GH, Harris TM, Wilson SE, Deeks SL. The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017. PLoS One. 2019;14(12):e0226353. doi:10.1371/journal.pone.0226353.
   PubMed Web of Science ®Google Scholar
• Chen K, Zhang X, Tao Y, Wang Y, Xue J, Liu C, Feng S, Yan Y, Chen Q, Tian J, et al. Hospitalization for invasive pneumococcal diseases in young children before use of 13-valent pneumococcal conjugate vaccine, Suzhou, China. Emerg Infect Dis. 2021;27(1):69–75. doi:10.3201/eid2701.181415.
   PubMed Web of Science ®Google Scholar
• Cai K, Wang Y, Guo Z, Xu X, Li H, Zhang Q. Clinical characteristics and antimicrobial resistance of pneumococcal isolates of pediatric invasive pneumococcal disease in China. Infect Drug Resist. 2018;11:2461–9. doi:10.2147/IDR.S183916.
   PubMed Web of Science ®Google Scholar
• Song P, Theodoratou E, Li X, Liu L, Chu Y, Black RE, Campbell H, Rudan I, Chan KY. Causes of death in children younger than five years in China in 2015: an updated analysis. J Glob Health. 2016;6(2):020802. doi:10.7189/jogh.06.020802.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang J, Shao X, Feng S, Xu X, Zheng B, Liu C, Dai Z, Jiang Q, Gessner BD, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study. Vaccine. 2021;39(33):4620–7. doi:10.1016/j.vaccine.2021.06.075.
   PubMed Web of Science ®Google Scholar
• Lu CY, Chiang CS, Chiu CH, Wang ET, Chen YY, Yao SM, Chang LY, Huang LM, Lin TY, Chou JH. Successful control of Streptococcus pneumoniae 19A replacement with a catch-up primary vaccination program in Taiwan. Clin Infect Dis. 2019;69(9):1581–7. doi:10.1093/cid/ciy1127.
   PubMed Web of Science ®Google Scholar
• Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355–67. doi:10.1038/s41579-018-0001-8.
   PubMed Web of Science ®Google Scholar
• Tvedskov ESF, Hovmand N, Benfield T, Tinggaard M. Pneumococcal carriage among children in low and lower-middle-income countries: a systematic review. Int J Infect Dis. 2022;115:1–7. doi:10.1016/j.ijid.2021.11.021.
   PubMed Web of Science ®Google Scholar
• Dagan R. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation. Expert Rev Vaccines. 2019;18(6):641–61. doi:10.1080/14760584.2019.1627207.
   PubMed Web of Science ®Google Scholar
• Shiri T, Datta S, Madan J, Tsertsvadze A, Royle P, Keeling MJ, McCarthy ND, Petrou S. Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(1):e51–e9. doi:10.1016/s2214-109x(16)30306-0.
   PubMed Web of Science ®Google Scholar
• Wysocki J, Brzostek J, Szymanski H, Tetiurka B, Toporowska-Kowalska E, Wasowska-Krolikowska K, Sarkozy DA, Giardina PC, Gruber WC, Emini EA, et al. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination. Vaccine. 2015;33(14):1719–25. doi:10.1016/j.vaccine.2015.02.005.
   PubMed Web of Science ®Google Scholar
• Frenck R Jr., Thompson A, Yeh SH, London A, Sidhu MS, Patterson S, Gruber WC, Emini EA, Scott DA, Gurtman A, et al. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2011;30(12):1086–91. doi:10.1097/INF.0b013e3182372c6a.
   PubMed Web of Science ®Google Scholar